First Evaluation Switching From Ropivacaine to Highly Concentrated Bupivacaine in Intrathecal Mixtures for Cancer Pain

ConclusionSwitching from ropivacaine to bupivacaine in IDDS appears more efficacious while remaining just as secure, and at lower cost.

Source: Neuromodulation: Technology at the Neural Interface - June 29, 2021 Category: Biotechnology Authors: Florent Bienfait, Sabrina Jubier ‐Hamon, Valérie Seegers, Yves‐Marie Pluchon, Nathalie Lebrec, Virginie Jaoul, François Boré, Thierry Delorme, Julien Robert, Martine Bellanger, Jérémy Sorrieul, Denis Dupoiron Tags: Clinical Research Source Type: research